Optinose to Present at the Jefferies Healthcare Conference

YARDLEY, Pa., June 02, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Jefferies Healthcare Conference on June 9, 2023 at 10:00 a.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About OptinoseOptinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor ContactJonathan Neely[email protected]267.521.0531

You May Also Be Interested In

• Countdown Awards Research Grant to Advance Mitochondrial Transplantation in Duchenne Muscular Dystrophy
• KBRA Assigns Preliminary Ratings to BSPDF 2026-FL5
• ARC Health Partners with The Waverly Group to Expand Access to Collaborative Pediatric Care in Connecticut